MS Views and News – a Patient Advocacy Organization that provides educational information for ALL affected by Multiple Sclerosis

Being Empowered with MS information IS beneficial. We Believe YOU (the MS Patients and Caregivers) should Be Empowered with Multiple Sclerosis information.

Visit our archived MS educational program video- recordings. Visit www.youtube.com/msviewsandnews

Visit our website: MS Views and News.org

joomla ecommerce template

Scroll to Review all the resources found on the left side of this blog site. Use our 'search by topic' tool, when wanting to find specific information

.

Disclaimer:

'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

==================================

Wednesday, April 24, 2013

Shrinkage of Brain Region May Signal Onset of Multiple Sclerosis


April 23, 2013

By Maureen Salamon
HealthDay Reporter

TUESDAY, April 23 (HealthDay News) -- Atrophy of a key brain area may become a new biomarker to predict the onset of multiple sclerosis, researchers say. If so, that would add to established criteria such as the presence of brain lesions to diagnose the progressive, incurable disorder.
Using special MRI images, scientists from three continents found that the thalamus -- which acts as a "relay center" for nervous-system signals -- had atrophied in nearly 43 percent of patients who had suffered an initial neurological episode that often comes before a multiple sclerosis (MS) diagnosis.
"The telling appearance of lesions, which is a hallmark of the disease, is only part of the pathology," said study author Dr. Robert Zivadinov, director of the Buffalo Neuroimaging Analysis Center at the University of Buffalo, in New York. "Our finding is more related to [initiating] clinical trials, to using thalamic volume as a new biomarker for testing and treatment, and to increasing awareness among investigators that this disease is more than just about lesions."
The study was published online April 23 in the journalRadiology.
Believed to be an autoimmune disorder, MS results in lesions on the brain and spinal cord that disrupt nerve signals to various parts of the body. Symptoms, which can come and go, include numbness, tingling, vision disturbances, problems walking, dizziness, and bowel and bladder problems.


Read More
..



USE OUR SHARE LINKS at the top of this page  - to provide this article to others



REMAIN up to date with MS News and Education
Visit: www.msviewsandnews.org  to register


.

No comments: